Opendata, web and dolomites

Bio-LP-1 SIGNED

A novel rapid environmental test for the human pathogen Legionella

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "Bio-LP-1" data sheet

The following table provides information about the project.

Coordinator
BIOPROBE DIAGNOSTICS LIMITED 

Organization address
address: FAIRWINDS BALLINACOURTY DUNGARVAN
city: CO WATERFORD
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 2˙826˙040 €
 EC max contribution 1˙978˙228 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2020
 Duration (year-month-day) from 2020-04-01   to  2022-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOPROBE DIAGNOSTICS LIMITED IE (CO WATERFORD) coordinator 844˙522.00
2    CONTROL MICROBIOLÓGICO BILACON SLU ES (LAS ROZAS) participant 661˙031.00
3    MYPOLS BIOTEC GMBH DE (KONSTANZ) participant 288˙925.00
4    GENAXXON BIOSCIENCE GMBH DE (ULM) participant 183˙750.00

Map

 Project objective

Traditional microbiological culture for Legionella bacteria takes up to 14 days to provide a result. While some rapid methodologies have been developed they require 2-3 tests to be completed meaning it can take 3 days for a result and they also require capital investments in costly specialised equipment.

Bio-LP-1 is a novel rapid test which has the capacity to transform the environmental global testing landscape for the human pathogen Legionella.

Bio-LP-1’s unique selling point is that it provides a complete identification of Legionella to the serogroup level in a single test using molecular technologies.

This is a diagnostic breakthrough, as all existing competitors can only offer 2 or 3 stage molecular tests to generate the equivalent result. The single test Bio-LP-1 product format is 5 x FASTER than the nearest competitor, Offers €319,200 pa savings for large test laboratories conducting at least 50,000 tests per year. Bio-LP-1 – offers a faster time to result; yields more robust information; requires less hands on time; requires no specialised equipment and ultimately has the potential for significant cost savings.

Current estimates predict that the global legionella testing market will reach $352.6 million by 2025 and that the water testing market is the fastest growing sector.

We have a best in class consortium: BPD - European experts in development and commercialisation of rapid microbial diagnostic solutions. myPOLs - leader in molecular biology reagent manufacturing. Genaxxon - European leader in sales of innovative molecular IVD products) Control Microbiológico - ENAC accredited large environmental testing laboratory.) BPD and myPOLS have previously collaborated in the development of Bio-Lp-1, over past 12 months to bring Bio-LP-1 to TRL 6

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIO-LP-1" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIO-LP-1" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

PAV-DT (2019)

A disruptive technology that enables low cost real-time monitoring of road pavement condition by any ordinary vehicle circulating on the road, and automatically designs plans for predictive maintenance.

Read More  

DERMAREP (2019)

Clinical validation and production upscaling of a novel product for healing of Pressure Ulcers, Leg Ulcers and Diabetic Foot Ulcers.

Read More  

De-RISC (2019)

De-RISC: Dependable Real-time Infrastructure for Safety-critical Computer

Read More